Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$24k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
6.8% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
New
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
2.0% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
8
users have liked this narrative
1
users have commented on this narrative
16
users have followed this narrative
8 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.9% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
9
users have liked this narrative
2
users have commented on this narrative
13
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
47.4% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
HealthStream
AN
AnalystLowTarget
Consensus Narrative from 2 Analysts
Rising Costs And Regulations Will Dampen Healthcare Demand Amid Resilience
Key Takeaways Healthcare sector shifts toward automation, AI, and consolidation threaten HealthStream's core revenue and future market size despite demographic tailwinds. Rising compliance, data privacy challenges, and higher infrastructure costs may curb margin growth and make customer acquisition and retention more difficult.
View narrative
US$28.00
FV
5.2% undervalued
intrinsic discount
3.97%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
A-Mark Precious Metals
AN
AnalystLowTarget
Consensus Narrative from 5 Analysts
Falling Physical Sales Will Squeeze Margins Yet Gold Will Persist
Key Takeaways Heavy reliance on acquisitions and volatile spot prices raises uncertainty about sustainable growth, with recent higher precious metal prices dampening new demand and volume. Rising competition from digital and larger online players, along with slow integration of acquired customers, threatens future margins and A-Mark's intermediary business model.
View narrative
US$28.00
FV
17.3% undervalued
intrinsic discount
6.81%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
Phibro Animal Health
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
Regulatory Pressures And Alternative Proteins Will Shrink Animal Health Market
Key Takeaways Shifting consumer preferences and regulatory pressures threaten to reduce market size, compress margins, and increase earnings volatility for Phibro's core animal health business. Growth challenges are intensified by industry consolidation, rising R&D costs, and increased difficulty in differentiating products against larger competitors.
View narrative
US$19.00
FV
67.6% overvalued
intrinsic discount
8.90%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
Quanex Building Products
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
European And US Weakness Will Persist And Resilience Will Emerge
Key Takeaways Execution on cost synergies and operational efficiency is strong, but unproven revenue synergies and regulatory costs may limit long-term margin and topline growth. Expansion efforts face risks from macroeconomic headwinds, volatile input costs, and competitive pressures that could constrain gains from secular industry trends.
View narrative
US$28.00
FV
22.6% undervalued
intrinsic discount
10.82%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
Guild Holdings
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
Rising Home Prices And Fintech Competition Will Squeeze Margins
Key Takeaways Overdependence on purchase mortgages and exposure to market headwinds threaten Guild's origination volumes, earnings, and long-term growth prospects. Rising competition, higher fixed costs, and regulatory pressures could erode margins and make it difficult for Guild to sustain profitability.
View narrative
US$18.00
FV
10.2% overvalued
intrinsic discount
12.10%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
Wabash National
AN
AnalystLowTarget
Consensus Narrative from 2 Analysts
E-commerce And Regulation Will Erode Traditional Trailer Demand
Key Takeaways Advancements in automation, electrification, and global competition threaten Wabash's core trailer business, leading to sustained margin pressure and vulnerability to demand cycles. Rising costs, labor shortages, and industry consolidation are likely to erode profitability and pose challenges to maintaining market share and long-term earnings power.
View narrative
US$9.50
FV
14.5% overvalued
intrinsic discount
6.68%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
Embecta
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
Global Healthcare Margins Will Erode Under Tightening Reimbursement Pressures
Key Takeaways Structural shifts toward prevention and novel diabetes therapies threaten long-term demand for Embecta's legacy insulin delivery products and overall market position. Intensifying cost pressures, regulatory burdens, and lagging product innovation expose Embecta to sustained margin compression and competitive stagnation.
View narrative
US$11.00
FV
24.0% overvalued
intrinsic discount
-0.66%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
Beazer Homes USA
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
Increasing Mortgage Rates And Aging Demographics Will Depress Home Sales
Key Takeaways Demographic shifts, higher mortgage rates, and affordability issues are likely to constrain long-term demand and pressure Beazer's sales growth and pricing power. Intensifying competition, regional concentration, and rising regulatory costs heighten risks to earnings stability, profitability, and shareholder value.
View narrative
US$23.00
FV
12.8% overvalued
intrinsic discount
2.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
ZipRecruiter
AN
AnalystLowTarget
Consensus Narrative from 5 Analysts
Internal Talent Shifts And Rising Costs Will Erode Market Potential
Key Takeaways Adoption of AI and internal hiring solutions threatens ZipRecruiter's growth, compressing its customer base and limiting demand for external recruitment platforms. Heavy dependence on unstable SMB clients and limited international reach increases revenue volatility and exposes the company to regional market risks.
View narrative
US$4.00
FV
8.5% overvalued
intrinsic discount
5.08%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
Value any company in seconds
Popular companies